Cargando…

Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey

BACKGROUND: Trachoma is targeted for elimination by 2020. World Health Organization advises districts to undertake surveillance when follicular trachoma (TF) <5% in children 1–9 years and mass antibiotic administration has ceased. There is a question if other tools could be used for surveillance...

Descripción completa

Detalles Bibliográficos
Autores principales:	West, Sheila K., Munoz, Beatriz, Weaver, Jerusha, Mrango, Zakayo, Dize, Laura, Gaydos, Charlotte, Quinn, Thomas C., Martin, Diana L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714879/ https://www.ncbi.nlm.nih.gov/pubmed/26771906 http://dx.doi.org/10.1371/journal.pntd.0004352

Ejemplares similares

Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania
por: Chen, Xinyi, et al.
Publicado: (2022)

Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area
por: West, Sheila K., et al.
Publicado: (2018)

Field Evaluation of the Cepheid GeneXpert Chlamydia trachomatis Assay for Detection of Infection in a Trachoma Endemic Community in Tanzania
por: Jenson, Alexander, et al.
Publicado: (2013)

The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children
por: West, Sheila K., et al.
Publicado: (2020)

The World Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and Added Benefit of Testing for Antibodies to Chlamydia trachomatis pgp3 Protein: NESTS Study
por: Zambrano, Andrea I., et al.
Publicado: (2016)

The Effect of Multiple Rounds of Mass Drug Administration on the Association between Ocular Chlamydia trachomatis Infection and Follicular Trachoma in Preschool-Aged Children
por: Lee, Jennifer S., et al.
Publicado: (2014)

Measuring Trachomatous Inflammation-Intense (TI) When Prevalence Is Low Provides Data on Infection With Chlamydia trachomatis
por: Zambrano, Andrea I., et al.
Publicado: (2017)

Impact of Biannual Azithromycin on Anemia in Preschool Children in Kilosa District, Tanzania: A Cluster-Randomized Clinical Trial
por: Bloch, Evan M., et al.
Publicado: (2020)

Evidence for contamination with C. trachomatis in the household environment of children with active Trachoma: A cross-sectional study in Kongwa, Tanzania
por: West, Sheila K., et al.
Publicado: (2019)

Causes of death after biannual azithromycin treatment: A community-level randomized clinical trial
por: Bloch, Evan M., et al.
Publicado: (2021)

Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial
por: West, Sheila K., et al.
Publicado: (2017)

Risk Factors for Ocular Infection with Chlamydia trachomatis in Children 6 Months following Mass Treatment in Tanzania
por: Cajas-Monson, Luis Carlos, et al.
Publicado: (2011)

Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
por: Potroz, Michael G., et al.
Publicado: (2015)

Serological Measures of Trachoma Transmission Intensity
por: Martin, Diana L., et al.
Publicado: (2015)

Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania
por: Bloch, Evan M., et al.
Publicado: (2020)

Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania
por: West, Sheila K., et al.
Publicado: (2011)

Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis
por: Hu, Victor H., et al.
Publicado: (2013)

The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study
por: Bloch, Evan M., et al.
Publicado: (2019)

Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration
por: Goodhew, Erica Brook, et al.
Publicado: (2014)

The Babesia observational antibody (BAOBAB) study: A cross-sectional evaluation of Babesia in two communities in Kilosa district, Tanzania
por: Bloch, Evan M., et al.
Publicado: (2019)

Population-Based Prevalence of Chlamydia trachomatis Infection and Antibodies in Four Districts with Varying Levels of Trachoma Endemicity in Amhara, Ethiopia
por: Nash, Scott D., et al.
Publicado: (2021)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Chlamydia trachomatis ompA Variants in Trachoma: What Do They Tell Us?
por: Andreasen, Aura A., et al.
Publicado: (2008)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district
por: Odonkor, Michelle, et al.
Publicado: (2021)

Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, Ethiopia
por: Pickering, Harry, et al.
Publicado: (2020)

The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining
por: Rahman, Salman A., et al.
Publicado: (2015)

Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea
por: Macleod, Colin K, et al.
Publicado: (2020)

Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection
por: Vasileva, Hristina, et al.
Publicado: (2018)

Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji
por: Macleod, Colin K., et al.
Publicado: (2016)

Correction: The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining
por: Rahman, Salman A., et al.
Publicado: (2015)

The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma
por: Gwyn, Sarah, et al.
Publicado: (2021)

Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study
por: Harding-Esch, Emma, et al.
Publicado: (2015)

CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs
por: Goodhew, E. Brook, et al.
Publicado: (2012)

Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009)

Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages
por: Andersson, Patiyan, et al.
Publicado: (2016)

Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
por: Last, Anna R., et al.
Publicado: (2014)

Estimating Household and Community Transmission of Ocular Chlamydia trachomatis
por: Blake, Isobel M., et al.
Publicado: (2009)

First Detection of Chlamydia trachomatis 'Swedish' Variant (nvCT) in a Russian Couple with Infertility
por: Feodorova, Valentina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dc1ua5u7bo2k5986nghuo9u7hh